Succinate prodrugs in combination with atropine and pralidoxime protect cerebral mitochondrial function in a rodent model of acute organophosphate poisoning
Sarah Piel(Düsseldorf University Hospital), Todd J. Kilbaugh(Children's Hospital of Philadelphia), Joshua Jose(Children's Hospital of Philadelphia), Johannes K. Ehinger(Lund University), David H. Jang(Children's Hospital of Philadelphia), Carly L. Clayman(Children's Hospital of Philadelphia), J. Laurenson Ward(Children's Hospital of Philadelphia), Joanna I. Janowska(Children's Hospital of Philadelphia), Eskil Elmér(Medicon Village), Malkah Sheldon(Children's Hospital of Philadelphia), Michael Karlsson(Lund University), Meagan J. McManus(Children's Hospital of Philadelphia), Jonathan Starr, Magnus J. Hansson(Medicon Village)
Cited by 11
Related Papers
Update on Immunologic Therapy With Anti–CTLA-4 Antibodies in Melanoma: Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management
|Seminars in Oncology|2010|170
Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency
|Nature Communications|2016|153
Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex I inhibition
|Acta Physiologica|2014|70
Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection
|Chemistry & Biology|2015|38